"Pfizer agreed to front BioNTech’s development costs and manage the clinical trials, manufacturing and distribution. BioNTech agreed to pay Pfizer back out of any profits, which would be split." nytimes.com/2020/11/21/us/…
"The government was ready to foot much of the development bill, guide the clinical trials and even deliver supplies to factories.
Dr. Bourla was not interested. As one of the world’s top vaccine producers, Pfizer did not need federal help in developing a new product"
Dr. Bourla was not interested. As one of the world’s top vaccine producers, Pfizer did not need federal help in developing a new product"
"Pfizer signed a $1.95B agreement in July to sell the federal government 100 million doses of its vaccine if it was successful, guaranteeing it a buyer... It also called on the Trump administration a few times to get access to manufacturing supplies. Otherwise it was on its own."
"Both Pfizer and Moderna were facing the problem of too few minority volunteers, but Pfizer had the deep pockets to solve it. The firm expanded its trial from 30,000 to 44,000, a decision... estimated cost the firm hundreds of millions of dollars."
• • •
Missing some Tweet in this thread? You can try to
force a refresh
